FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520248859> ?p ?o ?g. }

• W2520248859 abstract "The improvement of parasympathetic function seems to be an attractive therapeutic target in hypertensive patients. The parasympathetic function can be augmented by acetylcholinesterase inhibition. We investigated the chronic effect (16 weeks) of the acetylcholinesterase inhibitor pyridostigmine (PYR) on the hemodynamics [arterial pressure (AP) and heart rate (HR)], autonomic balance (parasympathetic tone, AP and pulse interval (PI) variability), spontaneous baroreflex sensitivity and cardiac function during the development of hypertension in SHR. PYR administration (minipumps, 1.5 mg/kg/day,n=6) started with SHR aging 5 weeks. Control SHR (n=7) was implanted with empty minipump. Mean AP (MAP, mmHg) was monitored every 4 weeks, by the tail-cuff method. At the end of 16 weeks, mean femoral AP (mmHg) was recorded in conscious state and methyl atropine allowed the evaluation of the vagal tone (bpm), while the combined administration of propranolol provided the intrinsic heart rate (IHR, bpm). Cardiac function was assessed, under isofluorane anesthesia, 24h after the hemodynamic recordings. PYR reduced the MAP during the first 8 weeks only (166±6 vs 185±6 in control), while after 16 weeks PYR produced: no change in HR (334±10 vs 354±13 in control); increase in vagal tone (132±8 vs 73±9 in control) and IHR (381±8 vs 340±3 in control); reduction of AP variance (42±6 vs 71±9 in control) without change of PI variance (69±12 vs 73±9 in control); no change of spontaneous baroreflex sensitivity (1.66±0.2 vs 1.75±0.1 bpm/mmHg in control); increase of the ejection fraction (65±5 vs 46±2 % in control). Nevertheless, it was not observed significant changes in cardiac output (32±5 vs 25±3 ml/min in control), +dPdt (9731±1079 vs 8746±461 mmHg/s in control), -dPdt (-9782±1079 vs -11195±1494 mmHg/s in control) and total peripheral resistance index (1.75±0.3 vs 2.53±0.5 mmHg/ml/min in control). In conclusion, PYR reduced the MAP of the SHR only at the beginning of the treatment (8 weeks), although chronically (16 weeks) increased cardiac vagal tone and IHR while reduced the AP variability combined with an increased ejection fraction. Therefore, the increase in parasympathetic function provided only slight benefic effects during the development of hypertension in SHR." @default.
• W2520248859 created "2016-09-23" @default.
• W2520248859 creator A5027789457 @default.
• W2520248859 creator A5032994985 @default.
• W2520248859 creator A5041309127 @default.
• W2520248859 creator A5079404862 @default.
• W2520248859 date "2012-09-01" @default.
• W2520248859 modified "2023-09-25" @default.
• W2520248859 title "Abstract 292: Cardiocirculatory Effect of the Increase of Parasympathetic Function with Pyridostigmine in Spontaneously Hypertensive Rats (SHR)." @default.
• W2520248859 doi "https://doi.org/10.1161/hyp.60.suppl_1.a292" @default.
• W2520248859 hasPublicationYear "2012" @default.
• W2520248859 type Work @default.
• W2520248859 sameAs 2520248859 @default.
• W2520248859 citedByCount "0" @default.
• W2520248859 crossrefType "journal-article" @default.
• W2520248859 hasAuthorship W2520248859A5027789457 @default.
• W2520248859 hasAuthorship W2520248859A5032994985 @default.
• W2520248859 hasAuthorship W2520248859A5041309127 @default.
• W2520248859 hasAuthorship W2520248859A5079404862 @default.
• W2520248859 hasConcept C126322002 @default.
• W2520248859 hasConcept C134018914 @default.
• W2520248859 hasConcept C164705383 @default.
• W2520248859 hasConcept C178853913 @default.
• W2520248859 hasConcept C191237925 @default.
• W2520248859 hasConcept C2775859210 @default.
• W2520248859 hasConcept C2776452961 @default.
• W2520248859 hasConcept C2777372248 @default.
• W2520248859 hasConcept C2777953023 @default.
• W2520248859 hasConcept C2778105408 @default.
• W2520248859 hasConcept C2778151854 @default.
• W2520248859 hasConcept C2779901103 @default.
• W2520248859 hasConcept C2780761756 @default.
• W2520248859 hasConcept C42219234 @default.
• W2520248859 hasConcept C71924100 @default.
• W2520248859 hasConcept C84393581 @default.
• W2520248859 hasConceptScore W2520248859C126322002 @default.
• W2520248859 hasConceptScore W2520248859C134018914 @default.
• W2520248859 hasConceptScore W2520248859C164705383 @default.
• W2520248859 hasConceptScore W2520248859C178853913 @default.
• W2520248859 hasConceptScore W2520248859C191237925 @default.
• W2520248859 hasConceptScore W2520248859C2775859210 @default.
• W2520248859 hasConceptScore W2520248859C2776452961 @default.
• W2520248859 hasConceptScore W2520248859C2777372248 @default.
• W2520248859 hasConceptScore W2520248859C2777953023 @default.
• W2520248859 hasConceptScore W2520248859C2778105408 @default.
• W2520248859 hasConceptScore W2520248859C2778151854 @default.
• W2520248859 hasConceptScore W2520248859C2779901103 @default.
• W2520248859 hasConceptScore W2520248859C2780761756 @default.
• W2520248859 hasConceptScore W2520248859C42219234 @default.
• W2520248859 hasConceptScore W2520248859C71924100 @default.
• W2520248859 hasConceptScore W2520248859C84393581 @default.
• W2520248859 hasIssue "suppl_1" @default.
• W2520248859 hasLocation W25202488591 @default.
• W2520248859 hasOpenAccess W2520248859 @default.
• W2520248859 hasPrimaryLocation W25202488591 @default.
• W2520248859 hasRelatedWork W2004082022 @default.
• W2520248859 hasRelatedWork W2048902303 @default.
• W2520248859 hasRelatedWork W2074069912 @default.
• W2520248859 hasRelatedWork W2087120737 @default.
• W2520248859 hasRelatedWork W2302735803 @default.
• W2520248859 hasRelatedWork W2331476712 @default.
• W2520248859 hasRelatedWork W2408475355 @default.
• W2520248859 hasRelatedWork W2414082531 @default.
• W2520248859 hasRelatedWork W33181892 @default.
• W2520248859 hasRelatedWork W39746024 @default.
• W2520248859 hasVolume "60" @default.
• W2520248859 isParatext "false" @default.
• W2520248859 isRetracted "false" @default.
• W2520248859 magId "2520248859" @default.
• W2520248859 workType "article" @default.